G
o
o
g
l
e
×
Please click
here
if you are not redirected within a few seconds.
All
Shopping
Images
News
Maps
Videos
Books
Search tools
Past week
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Clear
New painkiller precisely targets sites of chronic pain
New Atlas
Researchers have developed a non-addictive painkiller that remains inactive until it reaches sites of chronic pain. Instead of dulling the nerves that send...
2 days ago
Small Solutions for Big Problems in Drug Discovery and Delivery
News-Medical
Ijeoma Uchegbu discusses nanomedicine's role in improving medication adherence and developing non-addictive pain relief solutions at ELRIG Drug Discovery...
1 day ago
A Gender Difference in Acute Pain
Managed Healthcare Executive
A recent study from the University of California (UC) San Diego School of Medicine highlighted significant sex-based differences in pain processing,...
5 days ago
Sex-related differences in pain explain opioid addiction and efficacy
The Ticker
A new study by researchers at University of California San Diego has provided insights into why men and women experience and respond to pain treatments...
3 days ago
Global Analgesics Market Expected to Reach USD 81.1 Billion by 2033
IMARC Group
Global Analgesics Market Statistics: The global analgesics market is expected to reach USD 81.1 Billion by 2033, exhibiting a growth rate (CAGR) of 3.71%...
2 days ago
Artelo's Pain Drug Outperforms Naproxen in Key Study; FDA Clears Phase 1 Trial | ARTL Stock News
Stock Titan
Artelo Biosciences (ARTL) presented new data on ART26.12, their lead clinical Fatty Acid Binding Protein 5 (FABP5) inhibitor, for osteoarthritis (OA) pain...
1 day ago
CureLab Oncology Seeks to Revolutionize Chronic Pain Management with Novel p62-Based Therapy
PR Newswire
PRNewswire/ -- CureLab Oncology, a clinical-stage biotech company dedicated to pioneering innovative therapies, announced a patent application for an...
18 hours ago
Oxford Cannabinoid Technologies Achieves "Proof of Concept" for AI-Powered Drug Discovery
HIT Consultant
Oxford Cannabinoid Technologies (OCT) has announced the successful "proof of concept" of its AI-enabled drug discovery asset.
3 days ago
Non opioid Pain Patches Market: An Extensive Analysis Predicts Significant Future Growth
openPR.com
The latest study released on the Global Non-opioid Pain Patches Market by USD Analytics evaluates market size, trends, and forecast to 2032. The Non-opioid...
1 day ago
New painkiller remains inactive until it reaches sites of chronic pain
Tech Explorist
A team of international researchers including those from the University of Adelaide have taken a well-known chemical reaction as the basis of a new...
1 day ago